Aptorum Group Limited (NASDAQ:APM) Short Interest Down 41.3% in December

Aptorum Group Limited (NASDAQ:APM) was the target of a significant decline in short interest in December. As of December 15th, there was short interest totalling 11,100 shares, a decline of 41.3% from the November 30th total of 18,900 shares. Currently, 0.5% of the shares of the stock are sold short. Based on an average daily trading volume, of 41,300 shares, the days-to-cover ratio is currently 0.3 days.

Aptorum Group Stock Performance

Shares of NASDAQ APM traded up $0.22 during mid-day trading on Friday, reaching $1.08. 86,150 shares of the company were exchanged, compared to its average volume of 630,695. Aptorum Group has a 52 week low of $0.46 and a 52 week high of $17.49. The company’s 50 day moving average price is $1.03 and its 200 day moving average price is $2.42.

About Aptorum Group

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A.